Published On: Tue, Dec 8th, 2015

Reuters Exclusive: Valeant considers selling contact lens maker Paragon – sources

The FTC has been investigating Valeant for potentially cornering a portion of the lens market.

Valeant chief executive Michael Pearson

Valeant Pharmaceuticals is reaching out to potential buyers for its specialty contact lens manufacturing division, Paragon Vision Sciences, amid scrutiny from the Federal Trade Commission, according to two people familiar with the matter.

A sale of Paragon, which Valeant’s Bausch & Lomb unit purchased earlier this year for an undisclosed sum, would deal a blow to the specialty pharmaceutical company’s attempt to consolidate the market for gas permeable contact lenses, a type of rigid lens popular among people with keratoconus, a thinning disorder of the cornea, among other eye diseases.

The FTC has been investigating Valeant for potentially cornering a portion of the lens market…

Read the full story at Reuters,  BY CARL O’DONNELL

READ MORE: Michael Pearson

Herbalife Plunges As Ackman Vows To Unveil Enron-Like Fraud

From 2010, Valeant shares rose more than 10-fold to peak in August. Unfortunately, from a systemic perspective, just about every American is worse off as a result of Valeant’s strategy. Still, Valeant More…

Valeant chief executive Michael Pearson

Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman Sachs to secure loans made to chairman and chief More…

Teva CEO Erez Vigodman

Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker is More…

Valeant chief executive Michael Pearson

The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer of combined More…

Key Speakers At The Robin Hood Foundation Investors Forum

Last week pharmaceuticals company Allergan Inc, the Irvine California based maker of Botox received a second, increased, takeover offer from Quebec based Valeant Pharmaceuticals. The Valeant bid More…

Read more about: , , ,

About the Author

Wordpress site Developed by Fixing WordPress Problems